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The nervous and endocrine systems act
together to regulate all physiological
processes essential for the body homeosta-
sis control. Given the strict communica-
tion restrictions that the brain–blood bar-
rier (BBB) imposes, the interplay between
these two systems requires a variety of deli-
cate anatomical interfaces and physiolog-
ical mechanisms that guarantee the pre-
cise function of the neuroendocrine system
as a whole. The study of the mechanisms
by which hormones act in the brain in
order to regulate specific neuronal popu-
lations is a research topic rather neglected.
Our group studies the neuronal circuitries
and molecular mechanisms by which the
stomach-produced hormone ghrelin regu-
lates appetite and other physiological func-
tions. A clear notion of the brain targets
of peripheral ghrelin is essential for the
comprehensive understanding of the phys-
iological role of this hormone. Ghrelin is
called “the hunger hormone” since it is the
only known orexigenic peptide hormone.
The target for ghrelin orexigenic actions
is the brain, which contains a variety of
ghrelin-responsive nuclei; however, several
evidences suggest that the accessibility of
peripheral ghrelin to the brain is strik-
ingly low. Here, we briefly summarize the
current knowledge in this topic and dis-
cuss this intriguing neuroendocrinological
issue.
Ghrelin is a 28-amino acid octanoy-
lated peptide predominantly secreted from
endocrine cells located within the gas-
tric mucosa (1). Ghrelin acts via the
growth hormone secretagogue receptor 1A
(GHSR-1A), a G-protein-coupled recep-
tor highly expressed in the brain (2, 3).
Ghrelin’s central actions include mod-
ulation of the growth hormone secre-
tion, blood glucose homeostasis, stress
responses, and gastrointestinal tract motil-
ity, among others (4). Notably, ghrelin is
recognized as the only mammalian peptide
hormone able to increase appetite (5, 6).
Ghrelin orexigenic effects are rapid, since
food intake increases within 5–10min after
its systemic administration (7). Thus, the
ghrelin brain’s accessibility must be rele-
vant for this unique role of the hormone.
Direct ghrelin micro-injections, ranging
from 10 to 800 pmol, in several brain
areas potently increase food intake (6).
Ghrelin-induced food intake recruits neu-
ronal circuits, located in the hypothala-
mus and the brainstem, which regulate
appetite depending on the energy store
levels (6). In particular, ghrelin orexigenic
actions depends on the hypothalamic arcu-
ate nucleus (ARC), which highly expresses
GHSR-1A and is located in close appo-
sition to the median eminence (ME), an
important circumventricular organ (3, 8).
Ghrelin-induced food intake also occurs
at other GHSR-1A-expressing hypothala-
mic areas that lack obvious access to cir-
culating ghrelin, such as the paraventricu-
lar nucleus, the lateral hypothalamus, and
the ventromedial nucleus (9–11). Ghre-
lin orexigenic actions also take place at
the dorsal–vagal complex, which expresses
GHSR-1A and includes the nucleus of the
solitary tract, the dorsalmotor nucleus, and
the area postrema (AP), another important
circumventricular organ (3, 12). In addi-
tion, ghrelin regulates appetite and some
rewarding aspects of eating by directly act-
ing on the ventral tegmental area and other
centers of the mesolimbic pathway, which
also express GHSR-1A (13, 14). Thus, the
ghrelin-induced food intake depends on
the ability of peripheral ghrelin to impact
on these distributed brain targets.
Peptide hormones cannot freely enter
the brain. The BBB displays specific trans-
port mechanisms that can serve for par-
ticular peptides to gain access into the
brain through an otherwise impermeable
boundary. This transport mechanism can
include (a) receptor-mediated transcyto-
sis, (b) non-specific binding of positively
charged peptides to the cell membrane and
further transcytosis, (c) diffusion of mol-
ecules through the so-called extracellular
pathway, or (d) free transmembrane diffu-
sion, as seen for some small peptides (15).
The fenestrations of the specialized capil-
laries of circumventricular organs allow for
small peptides to penetrate the intercellular
space and eventually diffuse toward neigh-
boring brain areas (16). Notably, the ven-
tromedial ARC represents an exceptional
case of privileged permeability to blood-
borne factors due to presence of a fenes-
trated vasculature branching from the ME
(17). Peptide hormones can also reach the
brain via the cerebrospinal fluid (CSF) after
crossing the blood–CSF barrier at either
the choroids plexus, a specialized layer of
cuboidal ependymal cells that surround a
core of capillaries in some brain ventricles
and produce the CSF, and/or the hypo-
thalamic tanycytes, a specialized layer of
bipolar ependymal cells that line the floor
of the third ventricle and bridge the CSF
and the capillaries of theME (18,19).Addi-
tionally, some hormones signal to the brain
by acting on sensory circumventricular
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organs, such as the subfornical organ or
theAP,which detect plasmahormone levels
and transmit such information into spe-
cific brain regions (20). Currently, little is
known in terms of which of these mech-
anisms underlie central orexigenic ghrelin
actions.
In order to clarify the brain areas
mediating orexigenic effects of periph-
eral ghrelin, we have recently performed
a detailed neuroanatomical analysis in
mice of both the distribution of ghrelin-
induced increase of the marker of cellu-
lar activation c-Fos and the brain areas
accessible to fluorescent ghrelin (8). We
used a high (0.6 nmol/g BW) and a low
(0.06 nmol/g BW) doses of ghrelin that
induce a~17- and 2-fold increase of plasma
ghrelin concentrations 30min after treat-
ment, respectively. Interestingly, we found
that the smaller increment of circulating
ghrelin, which is sufficient to increase food
intake, exclusively impacts the ARC/ME
while the higher increment of circulat-
ing ghrelin increases c-Fos expression in
and access not only the ARC but also the
AP. In addition, the higher increment of
circulating ghrelin accesses the periven-
tricular hypothalamic regions and induces
c-Fos expression in a few extra-brain areas
such as the paraventricular nucleus and the
nucleus of the solitary tract. Notably, flu-
orescent ghrelin was detected in tanycyte-
like cells of the ME in all mice peripherally
treated with the tracer. Ghrelin internal-
ization in tanycytes has been recently con-
firmed in vivo and shown to also occur
in vitro (21). Importantly, we showed that
centrally administered ghrelin reaches and
increases c-Fos levels inmost of the GHSR-
1A-expressing brain areas (8, 22). In addi-
tion, we found that ARC-ablated mice fail
to eat in response to peripherally admin-
istered ghrelin but fully respond to the
orexigenic effects of the centrally adminis-
tered hormone. Thus, our data support the
notion that the ARC is the main target of
the orexigenic effects of peripheral ghrelin
in mice.
Our study stresses the fact that the
accessibility of peripheral ghrelin to the
brain is surprisingly limited and restricted
to specific brain areas. Figure 1 summa-
rizes our observations in terms of the
brain accessibility of peripherally admin-
istered fluorescent ghrelin, and describes
the potential mechanisms mediating this
phenomenon. A limited ghrelin brain
accessibility is in line with a seminal study
showing that radioactive ghrelin is trans-
ported across the BBB in the brain-to-
blood direction by a saturable systemwhile
blood-to-brain influx is extremely low
(23). In addition, very limited amounts
of peripherally injected ghrelin can be
detected in the CSF of ewes (24). Our study
adds neuroanatomical insights to these
reports by showing that the ghrelin acces-
sibility mainly occurs at the ARC/ME and,
to a lesser extent, the AP. Thus, peripheral
ghrelin seems to mainly reach and activate
brain areas located close to some circum-
ventricular organs, which would allow the
access of the circulating hormone to the
brain. In this regard, a recent study has
shown that ghrelin passively and rapidly
extravasates through fenestrated capillar-
ies of the ME and reaches nearby brain
regions (16). A higher accessibility at the
ARC/ME has been also shown for other
peptide hormones, including insulin and
leptin (25, 26). Peripheral ghrelin could
impact on specific neuronal circuits by
acting at the subfornical organ, which
expresses GHSR-1A; however, this path-
way is not related to food intake reg-
ulation (20). The presence of fluores-
cent ghrelin in both the tanycytes and
the choroids plexus (unpublished observa-
tion) and the hypothalamic periventricular
regions of peripherally injected mice sug-
gest a potential ghrelin transport from the
periphery to the CSF that could impact
on food intake regulation. Interestingly, it
has been proposed that tanycytic could
take up circulating leptin from the ME
and transport it toward the apical cell
pole in contact with the CSF (27). Fur-
ther studies are required in order to test
if ghrelin can access the brain via this
mechanism. Notably, the different pro-
file of c-Fos induction and fluorescent
ghrelin distribution found for the lower
and higher doses of ghrelin may indi-
cate that different mechanisms of entry
to the brain can take place depending on
plasma hormone levels. The observation
that very high increases in plasma ghrelin
level are not sufficient to access and/or acti-
vate deeper brain areas known to express
GHSR-1A support the notion that the
transport of ghrelin through the BBB in
a blood-to-brain direction is extremely
limited in mice. Importantly, our study
was performed using a single bolus of
fluorescent ghrelin and 15min after injec-
tion. Thus, our data do not invalidate
that ghrelin may act on other brain areas
through slower mechanisms either after a
sustained increase of the hormone con-
centration or over prolonged time peri-
ods. However, these potential slow ghrelin-
responsive pathways unlikely mediate the
rapid orexigenic effects of the hormone.
Interestingly, a recent article reported that
mice fail to increase food intake in response
to 0.0075 nmol/g BW of ghrelin, which
increases ~14-fold plasma ghrelin concen-
trations 10min after treatment, and con-
cluded that supraphysiologic plasma ghre-
lin levels are required in order to stimulate
appetite (28). The lack of an orexigenic
response may be related to the transient
nature of the ghrelin peak induced in these
conditions, given the short half-life of the
hormone (29). Still, these data also stress
the limited brain response, in terms of food
intake, to huge increases in plasma ghrelin
levels.
Overall, it seems clear that most of the
neuronal circuits known to regulate food
intake are sensitive to ghrelin. However,
the physiological relevance of the periph-
eral ghrelin signaling on these targets is
unclear given the limited brain accessibil-
ity of hormone. The possibility that some
of these neuronal circuits are engaged by
centrally produced ghrelin has been disre-
garded since it seems now clear that ghrelin
is not synthesized in the brain (30, 31). One
possibility is that the ghrelin brain accessi-
bility could be regulated under particular
physiological states. Indeed, the extent to
which the diffusion of molecules in the
ARC/ME occurs can be regulated in cir-
cumstances, such as fasting, by modulat-
ing the amount of vascular fenestrations
as well as by reorganizing the structure
of the tight-junctions between tanycytes
and limiting the diffusion of molecules to
the CSF (32). In terms of ghrelin, it has
been shown that the rate at which this
hormone is transported into the brain is
reduced in physiological states, such as obe-
sity or neonatal overnutrition (21, 33). It
has been also proposed that GHSR-1A can
act in a ghrelin-independent manner since
this receptor is able to both signal in the
absence of its ligand (34) and heterodimer-
ize with other G-protein-coupled receptors
in order to allosterically modulate their
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FIGURE 1 |The figure depicts the differential brain accessibility of a
high or a low dose of peripherally administered ghrelin and the
potential mechanisms mediating ghrelin brain accessibility. In our
study, a set of mice were subcutaneously injected with a high (0.6 nmol/g
BW) or a low (0.06 nmol/g BW) dose of fluorescent ghrelin and perfused
15min later. Brains were removed, post-fixed, cryoprotected, and
coronally cut. The neuroanatomical mapping of the presence of the ghrelin
tracer was performed by the analysis of the amplified
fluorescein-immunoreactive signal achieved by an anti-fluorescein antibody
followed by biotinylated secondary antibody, streptavidin–peroxidase, and
a chromogenic reaction. Stained brain sections were mounted and
bright-field images were acquired with a digital camera at 16 bit/pixel.
Finally, pixel intensity values were converted into optical density data by
taking the negative decimal logarithm of the original value divided by the
white flat field value and pseudocolored.Yellow to blue coloring represents
higher to lower levels of fluorescein-immunoreactive signal. (A) displays a
schematic illustration representing the distribution of fluorescein signal in a
mouse brain after the peripheral administration of the low (left) or the high
(right) dose of the ghrelin tracer. AP, area postrema; ARC, arcuate nucleus;
ME, median eminence; PVR, periventricular regions; 3V, third ventricle; 4V,
fourth ventricle. (B,C) show the actual images of mouse coronal brain
sections, at the rostro-caudal levels of the brain labeled with dashed lines
in the (A). Letters a, b, c, and d label corresponding brain levels and ghrelin
doses between (A) and (B,C). Insets in each microphotography show
higher magnification images. Scale bars: 500µm in low magnification,
100µm in high magnification. (D) displays a schematic diagram of the
potential mechanisms mediating the ghrelin brain accessibility. CVOs,
circumventricular organs; CSF, cerebrospinal fluid.
activity (35). Still, the impact of the con-
stitutive GHSR-1A signaling on the orex-
igenic actions of the peripheral ghrelin is
unclear. As usual, the more we know, the
more we realize how much we do not
know. Our knowledge about the ghrelin
system has notably increased lately; how-
ever, many questions remain open: which
are the mechanisms governing the ghre-
lin brain accessibility? Can the ghrelin
brain accessibility be regulated?What is the
physiological role of the ghrelin-responsive
neuronal circuits without obvious access to
peripheral ghrelin? Given its potent orex-
igenic effect, the ghrelin system has been
perceived as a potential pharmacological
target for compounds aimed to regulate
appetite. Thus, we think that research
efforts should be intensified in order to
solve these particular issues about the ghre-
lin physiology.
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